期刊
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
卷 31, 期 1, 页码 1-19出版社
SPRINGER
DOI: 10.1007/s10822-016-9974-4
关键词
Host-guest; Molecular recognition; Computer-aided drug design; Blind challenge; Binding affinity
资金
- National Institutes of Health (NIH) [GM061300, U01GM111528]
- Air Force Office of Scientific Research (AFOSR) for Basic Research Initiative (BRI) Grant [FA9550-12-1-6440414]
- National institutes of Health [1R01GM108889-01]
- National Science Foundation [CHE 1352608]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061300, R01GM108889, U01GM111528] Funding Source: NIH RePORTER
The ability to computationally predict protein-small molecule binding affinities with high accuracy would accelerate drug discovery and reduce its cost by eliminating rounds of trial-and-error synthesis and experimental evaluation of candidate ligands. As academic and industrial groups work toward this capability, there is an ongoing need for datasets that can be used to rigorously test new computational methods. Although protein-ligand data are clearly important for this purpose, their size and complexity make it difficult to obtain well-converged results and to troubleshoot computational methods. Host-guest systems offer a valuable alternative class of test cases, as they exemplify noncovalent molecular recognition but are far smaller and simpler. As a consequence, host-guest systems have been part of the prior two rounds of SAMPL prediction exercises, and they also figure in the present SAMPL5 round. In addition to being blinded, and thus avoiding biases that may arise in retrospective studies, the SAMPL challenges have the merit of focusing multiple researchers on a common set of molecular systems, so that methods may be compared and ideas exchanged. The present paper provides an overview of the host-guest component of SAMPL5, which centers on three different hosts, two octa-acids and a glycoluril-based molecular clip, and two different sets of guest molecules, in aqueous solution. A range of methods were applied, including electronic structure calculations with implicit solvent models; methods that combine empirical force fields with implicit solvent models; and explicit solvent free energy simulations. The most reliable methods tend to fall in the latter class, consistent with results in prior SAMPL rounds, but the level of accuracy is still below that sought for reliable computer-aided drug design. Advances in force field accuracy, modeling of protonation equilibria, electronic structure methods, and solvent models, hold promise for future improvements.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据